2013
DOI: 10.1155/2013/971760
|View full text |Cite
|
Sign up to set email alerts
|

Revisiting the Cutaneous Impact of Oral Hormone Replacement Therapy

Abstract: Menopause is a key point moment in the specific aging process of women. It represents a universal evolution in life. Its initiation is defined by a 12-month amenorrhea following the ultimate menstrual period. It encompasses a series of different biologic and physiologic characteristics. This period of life appears to spot a decline in a series of skin functional performances initiating tissue atrophy, withering, and slackness. Any part of the skin is possibly altered, including the epidermis, dermis, hypodermi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

1
17
0
2

Year Published

2014
2014
2024
2024

Publication Types

Select...
4
3
2

Relationship

1
8

Authors

Journals

citations
Cited by 32 publications
(20 citation statements)
references
References 46 publications
1
17
0
2
Order By: Relevance
“…Reduced estrogen levels during menopause affect skin components with estrogen receptors, particularly in epidermal cells and sebaceous glands. 60 By contrast, androgenic hormone levels do not decline significantly during this period. Although the response to this new ratio of sexual hormones is often clinically mistaken for the natural functional decline of the skin, menopause can increase xerosis, changes in texture and capillary density, and dermal atrophy.…”
Section: Systemic Morbidities and Drugsmentioning
confidence: 79%
“…Reduced estrogen levels during menopause affect skin components with estrogen receptors, particularly in epidermal cells and sebaceous glands. 60 By contrast, androgenic hormone levels do not decline significantly during this period. Although the response to this new ratio of sexual hormones is often clinically mistaken for the natural functional decline of the skin, menopause can increase xerosis, changes in texture and capillary density, and dermal atrophy.…”
Section: Systemic Morbidities and Drugsmentioning
confidence: 79%
“…postmenopausal women. Indeed, HRT controls in part the dermal thickness and laxity, and the collagen content and density, as well as the tissue mechanical reactivity to stress [237]. Physicians and patients have become extremely reluctant concerning HRT following the WHI study.…”
Section: H Hormone Replacement Therapymentioning
confidence: 99%
“…The deleterious effect of ultraviolet light on specific skin structures is beyond doubt 4. In addition, endocrine factors are clearly involved in the dermal thinning that occurs during estrogen reduction in the climacteric period 511. Hence, hormonal aging with impaired tissue trophicity is likely superimposed on the effects of chronic sun exposure during the global process of facial skin aging.…”
Section: Introductionmentioning
confidence: 99%